Page last updated: 2024-08-25

5-hydroxymethylcytosine and Adenocarcinoma

5-hydroxymethylcytosine has been researched along with Adenocarcinoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Allen, EG; Chang, MY; Cheng, Y; Jin, MH; Jin, P; Liu, H; Shu, Q; Wang, X; Xu, T1
Cao, F; Guo, Z; He, Y; Hu, X; Li, A; Liu, H; Tu, K; Wei, A; Xia, L; Xie, D; Yuan, J; Zhang, J1
Lai, M; Tian, Y; Zhang, H; Zhong, A1
Akazawa, Y; Hayashi, T; Murakami, T; Nagahara, A; Saito, T; Tsuyama, S; Ueyama, H; Watanabe, S; Yanai, Y; Yao, T; Yatagai, N1
Bissonnette, MB; Butun, F; Chapman, CG; Chuang, A; Godley, LA; Kwon, JH; Madzo, J; Mariani, CJ; Meckel, K; Wu, F1
Argani, P; Chaux, A; De Marzo, AM; Esopi, DM; Gerber, J; Haffner, MC; Iacobuzio-Donahue, C; Meeker, AK; Nelson, WG; Netto, GJ; Pellakuru, LG; Toubaji, A; Yegnasubramanian, S1

Other Studies

6 other study(ies) available for 5-hydroxymethylcytosine and Adenocarcinoma

ArticleYear
Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma.
    DNA and cell biology, 2019, Volume: 38, Issue:12

    Topics: 5-Methylcytosine; Adenocarcinoma; Case-Control Studies; DNA Methylation; Epigenesis, Genetic; Genome, Human; Humans; Stomach Neoplasms

2019
Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer.
    Clinical epigenetics, 2020, 07-23, Volume: 12, Issue:1

    Topics: 5-Methylcytosine; Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell-Free Nucleic Acids; Epigenesis, Genetic; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity

2020
DNA hydroxymethylation of colorectal primary carcinoma and its association with survival.
    Journal of surgical oncology, 2018, Volume: 117, Issue:5

    Topics: 5-Methylcytosine; Adenocarcinoma; Adenocarcinoma, Mucinous; Biomarkers, Tumor; Colorectal Neoplasms; DNA Methylation; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Rate

2018
TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
    Virchows Archiv : an international journal of pathology, 2019, Volume: 474, Issue:3

    Topics: 5-Methylcytosine; Adenocarcinoma; Aged; Aged, 80 and over; Ataxia Telangiectasia Mutated Proteins; Biomarkers, Tumor; Cell Differentiation; DNA Methylation; Female; Gene Silencing; Humans; Loss of Heterozygosity; Lymphatic Metastasis; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Neoplasm Staging; Promoter Regions, Genetic; Proto-Oncogene Proteins; Stomach Neoplasms; Treatment Outcome; Tumor Suppressor Protein p53

2019
TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer.
    Scientific reports, 2015, Dec-03, Volume: 5

    Topics: 5-Methylcytosine; Adenocarcinoma; Binding Sites; Cell Differentiation; Cell Line, Tumor; Colon; Colonic Neoplasms; Cytosine; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Mixed Function Oxygenases; Proto-Oncogene Proteins; Transcription Factors

2015
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.
    Oncotarget, 2011, Volume: 2, Issue:8

    Topics: 5-Methylcytosine; Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Differentiation; Colonic Neoplasms; Cytosine; Down-Regulation; Embryo, Mammalian; Female; Gestational Age; HEK293 Cells; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Prostatic Neoplasms; Stem Cells

2011